Connect with us

Cannabis News

Giving Up on Legalization? – Cannabis Industry Titans Throw in the Towel on Lobbyist in Washington

Published

on


cannabis industry lobby groups

A recent report from Stat News indicates a decrease in federal lobbying efforts by cannabis industry operators. Notably, Curaleaf, a significant player in the industry, reduced its lobbying spending in Washington, D.C., by almost 40% during the first half of the year compared to its peak spending in 2019. Furthermore, both Columbia Care and Pax Labs took more drastic measures by eliminating their lobbying teams.

 

In response to this trend, Aaron Smith, co-founder and CEO of the National Cannabis Industry Association (NCIA), which actively lobbies lawmakers, expressed concern. He described it as a “cruel irony” that businesses are cutting back on government relations spending when advocacy is essential for the industry’s success.

 

The NCIA spent $100,000 on lobbying this year, according to federal filings cited by Stat, a significant decrease from the $285,000 spent during the first half of 2019. Conversely, the U.S. Cannabis Council spent $150,000 on lobbying activities in the most recent quarter and intends to keep spending at or above this amount going forward. Additionally, the group has started a super PAC to build a large and diverse coalition.

 

The American Trade Association for Cannabis and Hemp, which began lobbying in late 2019, has modestly increased its lobbying in recent months, spending $50,000 this year. In 2022, the firm paid $50,000 for an entire year of lobbying.

 

However, two firms focusing on lobbying for cannabis reforms, the Cannabis Trade Federation and the Global Alliance for Cannabis Commerce, have reportedly folded entirely, according to the report.

 

Adam Goers, the senior vice president of corporate affairs for Columbia Care, acknowledged that although there may be less company spending on lobbying, the resources allocated are now more pragmatic and focused. As the cannabis industry faces ongoing regulatory challenges, effective lobbying efforts remain critical to navigating the evolving landscape.

 

Impact of Shifting Political Landscape on Cannabis Lobbying

 

The shift in the political landscape around marijuana legalisation can be traced to decreased federal lobbying spending by cannabis business operators. While many states have legalised medical and recreational marijuana, the federal government continues to classify it as a Schedule I restricted substance, resulting in inconsistencies between state and federal legislation. Because of the glacial pace of federal marijuana legislation and the lack of universal laws, cannabis businesses have hesitated to invest resources in lobbying activities.

 

The change in political administrations can also influence cannabis lobbying. Different administrations may prioritise different issues, impacting the trajectory of federal cannabis legislation and regulations—this dynamic challenges cannabis operators seeking to shape federal policies and advocate for the industry’s interests.

 

As the cannabis industry grows and evolves, effective lobbying efforts remain crucial for influencing federal lawmakers and policymakers. Advocacy is essential for advancing federal marijuana reform, addressing banking and tax issues, and resolving industry regulatory challenges. While the decline in lobbying spending reflects the current political climate, it highlights the need for strategic and targeted advocacy efforts to ensure the long-term success and growth of the cannabis industry.

 

Challenges and Strategies for Effective Cannabis Lobbying

 

The reduced federal lobbying spending by cannabis industry operators has prompted them to reassess their strategies for effective advocacy. Navigating the complexities of the federal political landscape requires a thoughtful approach to address the challenges posed by marijuana’s current Schedule I controlled substance classification.

 

One of the critical challenges faced by cannabis operators is the lack of uniform federal regulations. The absence of clear guidelines creates uncertainty and inhibits the industry’s growth and investment potential. Effective lobbying efforts should focus on advocating for consistent and comprehensive federal regulations that align with the evolving state-level marijuana policies. By seeking clarity and standardisation in federal laws, cannabis operators can create a more stable and predictable business environment.

 

The disparity between state and federal marijuana laws also challenges the industry. To address this, lobbying efforts should promote federal legalization respecting states’ rights to implement their cannabis policies. By supporting bills that recognise and appreciate the decisions made by individual states regarding marijuana legalisation, the cannabis industry can gain broader support among lawmakers and bridge the gap between state and federal laws.

 

Furthermore, lobbying efforts should prioritise the reform of outdated federal banking and tax regulations that disproportionately burden cannabis businesses. The current restrictions on banking services and the application of Section 280E of the federal tax code limit the industry’s financial growth and viability. Advocating for fair and equitable treatment in these areas is essential for fostering the industry’s development and levelling the playing field with other sectors.

 

 

The Impact of Reduced Lobbying on the Cannabis Industry

 

The decline in federal lobbying spending by cannabis operators can impact the industry’s growth, regulatory environment, and overall competitiveness. With reduced resources dedicated to lobbying, cannabis businesses may face challenges in shaping federal policies and advancing their interests in a complex and rapidly evolving landscape.

 

One significant consequence of reduced lobbying efforts is the potential for slower progress in federal marijuana reform. Effective advocacy is critical in influencing lawmakers and policymakers to support cannabis-friendly legislation. Without sufficient lobbying, important bills addressing issues such as decriminalization, taxation, and access to financial services may face delays or more significant legislative obstacles. As a result, the cannabis industry could experience slower growth and be subject to a less favorable regulatory environment.

 

Lower lobbying spending may impact the industry’s ability to address banking and financial concerns. Access to standard financial services remains a key barrier for cannabis entrepreneurs, limiting their capacity to conduct business efficiently and safely. Practical lobbying efforts can aid in passing legislation that allows the cannabis industry better access to banking and financial services, thus levelling the playing field and establishing a more robust and stable economic environment.

 

Additionally, the reduced lobbying spending may affect the industry’s ability to advocate for social equity and inclusion within the cannabis sector. As the industry continues to grow, it is essential to ensure that it is representative and inclusive, addressing the historical disparities and injustices related to cannabis prohibition. Advocating for policies that promote diversity and social equity within the cannabis space requires dedicated resources and lobbying efforts. With reduced funding allocated to lobbying, there may be a risk of losing momentum in addressing these crucial social justice issues.

 

Bottom Line

 

The decline in federal lobbying spending by cannabis industry operators reflects the challenges and complexities they face in navigating the shifting political landscape. While some major players have reduced or eliminated their lobbying efforts, others continue to strategise and invest in advocacy to influence federal lawmakers and advance the industry’s interests. Reduced lobbying can affect the industry’s growth, regulatory environment, and social equity initiatives. As the cannabis sector evolves, effective lobbying remains critical for driving federal marijuana reform, addressing financial barriers, and fostering a diverse and inclusive industry. Successful advocacy efforts will be essential in shaping a favourable regulatory framework and ensuring the long-term success of the cannabis industry in the United States.

 

BIG PHARMA LOBBYS AGAINST WEED, READ ON…

BIG PHARMA AGAINST CANNABIS

WHY IS THE BIG PHARMA LOBBYIST AGAINST LEGALIZATION?



Source link

Cannabis News

Is Kratom Addictive? Understanding Dependence, Risks, and Safe Usage

Published

on

By


is kratom addictive

Is kratom addictive? Discover the potential for dependence on Kratom, the risks involved with its use, and how to approach its consumption responsibly.

From 2011 to 2017, over 1,800 calls to poison centers involved kratom in the U.S. This significant number highlights the concern regarding kratom addiction.

However, without Food and Drug Administration (FDA) oversight, and due to various consumption methods like teas and capsules, there are significant health risks. Safe use of kratom is now in question due to these issues.

Research debates how dependence develops, outlining signs like loss of control and withdrawal symptoms. These signs are seen in regular kratom users. Ironically, some people switch from drugs like heroin to kratom, looking for a legal alternative.

Understanding Kratom: Origins and Prevalence

Kratom comes from the Mitragyna speciosa tree in Southeast Asia. It can act like a stimulant or like opioids, based on how much you take. People use it in different ways, for a small energy boost or stronger effects at higher doses.

The legal status of kratom in the U.S. is complicated and changing. It’s a hot topic because some worry about its misuse. It’s still legal in several states. This shows how different places handle drug rules. The National Institute on Drug Abuse is looking into its medical benefits. But, the FDA hasn’t approved it for medical use yet. The DEA calls it a “drug of concern,” which means policies might change.

  • From 2011 to 2017, poison control centers in the U.S. got over 1,800 reports about kratom. This shows it’s widely used and might pose health risks.

  • Kratom’s main ingredients bind to opioid receptors very strongly, stronger than morphine even. This fact is key to understanding its effects.

  • As more people use kratom, more are reporting serious health problems. These include liver and heart issues, and tough withdrawal symptoms, particularly in those already sick.

The statistics show mounting worries about kratom in the U.S. As its use grows, it’s becoming more important to health policies and laws. What happens next will depend on further research and legal decisions.

Is Kratom Addictive: Investigating the Substance’s Nature

The question of kratom’s addictiveness focuses on how it affects brain receptors and its long-term health implications. The ongoing debate highlights concerns about dependence and the risk of addiction. Scientists are closely looking at these issues.

How Kratom Works in the Brain

Kratom’s main alkaloids, mitragynine and 7-hydroxymitragynine, bind to the brain’s opioid receptors, similar to painkillers and narcotics. This connection suggests a potential risk of dependence. These alkaloids are key to kratom’s pain relief but also point to possible addiction concerns, especially with frequent, high-dose usage.

Patterns and Consequences of Long-term Use

  • Using kratom often, especially in large doses, can increase the risk of dependence and intense withdrawal symptoms, similar to opioid withdrawal.

  • Although some use it for pain or to improve mood, long-term kratom users might see serious health problems, like liver damage and mental health issues.

  • Withdrawal symptoms, including irritability, nausea, and sleep problems, show kratom’s impact on one’s physical and mental health.

Assessment of Addiction Risks

Studies indicate a significant risk of addiction to kratom, especially with high doses or frequent use. Dependence develops as the body gets used to kratom, leading to tolerance and a need for more to feel its effects. Withdrawal symptoms emphasize this risk, as highlighted by health experts.

Physiological Effects: Kratom’s Impact on the Body

There is a lot of debate about the safety and use of kratom. This herbal extract comes from the Mitragyna speciosa plant. It has drawn attention for its possible harmful effects on the body. The FDA has issued many warnings about kratom, raising safety concerns.

  • Kratom Adverse Effects: Kratom users have reported side effects like nausea, vomiting, and confusion. More serious issues include high blood pressure and liver damage. These problems highlight the risks of using kratom.

  • Herbal Extract Safety: Some kratom products contain heavy metals and pathogens. These can cause severe health issues, including death. This shows the importance of safety in herbal products.

  • FDA Warnings and Regulations: The FDA has linked kratom to over 35 deaths and warns against using it. They point out the lack of medical uses and the risk of addiction.

  • Physiological Impact: Kratom’s effects depend on the dose and the user’s body. Yet, it can lead to dangerous outcomes like liver damage and seizures.

  • Safety Concerns from Authorities: Federal agencies like the DEA are worried about kratom’s safety. Although not a controlled substance, monitoring suggests users should be careful.

Kratom might offer temporary relief for some ailments, but it comes with significant risks. The FDA’s warnings should make people think twice. If considering kratom, it’s crucial to talk to a doctor first. Experts stress the need for safety and caution with herbal extracts.

Conclusion

Kratom’s role in health and regulation is complex, with views and research findings widely varied. Some people use kratom for its claimed health benefits, but it’s a hot topic. Experts advise caution and suggest consulting a doctor before using kratom due to the unclear effects.

Clinical studies using scores like SOWS and COWS haven’t confirmed withdrawal symptoms from kratom. This adds to the debate, especially when some users report withdrawal. This makes kratom a controversial subject among different findings and user experiences.

When it comes to treating opioid addiction, kratom can be both helpful and harmful. Some have used it successfully to fight addiction. Yet, some states have banned it. This highlights the need for regulations and consistent product quality. It also raises questions about kratom’s legal status due to mixed actions by authorities.

The situation shows how complex kratom is in the realm of substance use and law. Without clear evidence supporting either its benefits or risks, it poses a challenge. More research is needed to guide regulations and health advice. For now, anyone thinking of using kratom should be careful, seek medical advice, and keep up with laws and health guidelines.

 

WHAT IS KRATOM ANYWAY? READ ON…

WHAT IS KRATOM

WHAT IS KRATOM AND WHY ARE YOU HEARING ABOUT IT NOW?



Source link

Continue Reading

Cannabis News

New Rule, December 5: Oregon Cannabis Retailers, Processors and Labor Peace Agreements

Published

on

By


Oregon’s Measure 119 passed last week, as expected. This means that as of December 5th, every OLCC licensed retailer, processor, researcher and testing lab must secure a labor peace agreement before OLCC will approve a new or renewal license application. The labor peace agreement must be with a “bona fide labor organization.”

I previewed M119 back in September, explaining:

Compulsory peace agreements aren’t anything new in cannabis, although it would be something different here in Oregon. California, for example, requires labor peace agreements for many of its cannabis licensees, and has for many years. We had clients struggle with the concept initially, and we saw some fumbled rollouts, but people eventually adjusted.

Measure 119 further provides that retailers and processors would be required to remain neutral, under the peace agreements, when labor organizations communicate with employees about collective bargaining rights “with any licensure or renewal application.”

M119 may be legally problematic

I’m not a First Amendment lawyer, but it’s not clear to me that an Oregon business can be constrained from speaking with employees– regardless of what M119 provides. Oregon’s speech protections are extremely broad, which is why we have a naked bike ride, tons of strip clubs and no campaign finance restrictions.

I’m also not a labor lawyer, but I’m told M119 could hit a snag on the National Labor Relations Act.

I’ve run these concepts by an Oregon First Amendment lawyer and a couple of labor lawyers, and all confirmed to me that M119 has real exposure. I found that feedback interesting, because M119 sponsors would have understood this when they set out signature gathering. Back in September, I wrote:

The United Food and Commercial Workers Local 555 spent a good deal of money to get Measure 119 on the ballot, rounding up some 163,000 signatures when only 117,173 were required. This follows on a stymied effort to get House Bill 3183 passed last year, which would have accomplished the same thing legislatively.

HB 3183 failed after a couple of advisory letters from the State of Oregon, Legislative Counsel Committee (see here and here). Those letters discussed preemption exposure for what is now M119 under the National Labor Relations Act, The Taft Hartley Act, and other federal laws. Oregon Business and Industry, the largest business group in the state, also submitted opposing testimony, highlighting legal exposure.

As to the First Amendment issues, anyone watching this is advised to follow litigation recently brought by Ctrl Alt Destroy, Inc., on a similar requirement in California.

So let’s see how that goes, and let’s see if anyone in the Oregon cannabis space wants to make a run at litigating M119. For now, credit to UFCW Local 555, I guess, for not giving up and for getting this thing on the ballot. And for having some fun by slipping a Rickroll into the voter pamphlet. I’m sure that won a few people over.

The OLCC process

I don’t have any information yet on what OLCC is going to do ahead of the December 5th deadline. It’s worth noting that, in addition to California, other recreational cannabis states including New York, New Jersey, Rhode Island, Connecticut and Delaware all have similar requirements. Most likely, OLCC will put out an FAQ page very soon that looks something like this and licensees will need to upload something or other to CAMP with respect to any post-December 5th application or renewal.

As far as OLCC licensees negotiating these agreements, the best approach would be to speak with experienced labor counsel. Labor law is highly specialized, and negotiating a labor peace agreement with any outfit claiming to be a “bona fide labor organization” is not a typical exercise.

For now, this is just one more thing for licensed cannabis businesses to comply with. Please reach out to us if you have any questions or need a referral.



Source link

Continue Reading

Cannabis News

The CBD Dog Treat Guide

Published

on

By


CBD dog treats good or bad

As the popularity of CBD (cannabidiol) continues to rise, many pet owners are exploring its potential benefits for their furry companions. CBD is derived from the hemp plant and is known for its therapeutic properties, which may help alleviate anxiety, pain, inflammation, and other health issues in dogs. However, when considering CBD treats for your dog, it’s crucial to understand the ingredients that go into these products. This article will delve into the essential ingredients to look for in CBD treats, their benefits, potential risks, and how to choose the right product for your canine friend.

 

Understanding CBD and Its Benefits for Dogs

 

Before we dive into the ingredients, it’s important to understand what CBD is and how it can benefit dogs. CBD is a non-psychoactive compound found in cannabis plants. Unlike THC (tetrahydrocannabinol), which can produce a “high,” CBD does not have intoxicating effects. Instead, it interacts with the endocannabinoid system (ECS) in both humans and animals, which plays a crucial role in regulating various physiological processes.

 

Potential Benefits of CBD for Dogs

 

  • Anxiety Relief: Many dogs experience anxiety due to various factors such as loud noises, separation from their owners, or changes in their environment. CBD may help reduce anxiety levels by promoting a sense of calm.

 

 

 

 

 

 

Choosing the Right CBD Treats

 

When selecting CBD treats for your dog, it’s essential to look beyond just the CBD content. The overall quality of the treat is equally important. Here are some key ingredients you should be aware of:

 

1. High-Quality CBD Oil

 

The foundation of any good CBD treat is the quality of the CBD oil used. Look for treats that contain:

 

  • Full-Spectrum or Broad-Spectrum CBD: Full-spectrum products contain all cannabinoids found in the hemp plant, including trace amounts of THC (below 0.3% as per legal standards). Broad-spectrum products contain multiple cannabinoids but no THC. Both types can provide an “entourage effect,” enhancing the therapeutic benefits.

 

 

 

2. Natural Ingredients

 

Just like human food, the ingredients in your dog’s treats matter significantly. Look for treats made with natural ingredients rather than artificial additives or preservatives. Here are some beneficial components:

 

Whole grains like oat flour or brown rice flour provide essential nutrients and fiber that support digestive health. They are also a good source of energy for active dogs.

 

Healthy fats are vital for maintaining your dog’s coat and skin health. Ingredients like coconut oil or peanut butter not only enhance flavor but also provide beneficial fatty acids that support overall well-being.

 

Incorporating fruits and vegetables into your dog’s treats can boost their nutritional value:

 

 

 

 

 

To make treats more appealing without resorting to artificial flavors, look for natural flavorings like chicken broth or carob (a chocolate substitute safe for dogs). These ingredients can enhance taste while keeping the treat healthy.

 

3. Functional Ingredients

 

Some treats may include additional functional ingredients designed to address specific health concerns:

 

 

These compounds are often included in joint support treats to help maintain joint health and mobility, especially in older dogs or those with arthritis.

 

 

Probiotics can promote gut health by supporting a healthy balance of bacteria in your dog’s digestive system.

 

 

Certain herbs like chamomile or ginger may offer calming effects or aid digestion. Always ensure these herbs are safe for canine consumption before choosing treats containing them.

 

Ingredients to Avoid

 

While there are many beneficial ingredients to seek out, it’s equally important to know which ones to avoid:

 

1. Artificial Additives

 

Many commercial pet treats contain artificial colors, flavors, and preservatives that can be harmful to your dog’s health. These additives may lead to allergic reactions or other health issues over time.

 

2. High Sugar Content

 

Just like humans, dogs do not need excessive sugar in their diets. Treats high in sugar can lead to obesity and dental problems.

 

3. Low-Quality Fillers

 

Avoid treats with low-quality fillers such as corn syrup or by-products that do not provide any nutritional value.

 

4. THC (Tetrahydrocannabinol)

Always ensure that any CBD product you choose contains less than 0.3% THC to avoid any psychoactive effects on your dog.

 

How to Introduce CBD Treats Safely

 

When introducing any new treat into your dog’s diet—especially one containing CBD—it’s essential to do so gradually:

 

  • Start Small: Begin with a small amount of the treat to see how your dog reacts.

  • Monitor Your Dog: Observe your dog for any adverse reactions such as changes in behavior or gastrointestinal upset.

  • Adjust Dosage as Needed: Depending on your dog’s size and needs, you may need to adjust the dosage over time.

  • Consult Your Veterinarian: Before starting any new supplement regimen, including CBD treats, consult with your veterinarian—especially if your dog has existing health conditions or is taking other medications.

 

Conclusion

 

CBD treats can be a beneficial addition to your dog’s diet when chosen carefully with attention to ingredient quality and safety. By understanding what goes into these treats—such as high-quality CBD oil, natural ingredients, functional additives—and knowing what to avoid, you can make informed decisions that support your dog’s health and well-being.

Always prioritize transparency from manufacturers regarding ingredient sourcing and product testing; this will ensure you’re providing your furry friend with safe and effective options tailored to their needs. With proper research and guidance from a veterinarian, you can confidently explore the potential benefits of CBD treats for your beloved pet while ensuring they enjoy a tasty snack that’s good for them too!

 

CBD OIL FOR DOGS, READ ON…

CAN CBD OIL HELP DOGS

WHAT CONDITIONS CAN CBD HELP TREAT IT DOGS?



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media